Bo Chi

1.3k total citations
10 papers, 772 citations indexed

About

Bo Chi is a scholar working on Epidemiology, Infectious Diseases and Periodontics. According to data from OpenAlex, Bo Chi has authored 10 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Periodontics. Recurrent topics in Bo Chi's work include Oral microbiology and periodontitis research (3 papers), Respiratory viral infections research (3 papers) and Viral Infections and Vectors (3 papers). Bo Chi is often cited by papers focused on Oral microbiology and periodontitis research (3 papers), Respiratory viral infections research (3 papers) and Viral Infections and Vectors (3 papers). Bo Chi collaborates with scholars based in United States, Belgium and Canada. Bo Chi's co-authors include Kirsten Spann, Ronald L. Rabin, Peter L. Collins, Howard K. Kuramitsu, Mingshan Qi, Sarita Chauhan, Ronald J. Limberger, Judy A. Beeler, Harold Dickensheets and Laure Dumoutier and has published in prestigious journals such as Journal of Virology, Clinical Cancer Research and Journal of Bacteriology.

In The Last Decade

Bo Chi

10 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Chi United States 10 385 269 169 140 113 10 772
E. Kaitlynn Allen United States 13 206 0.5× 312 1.2× 188 1.1× 97 0.7× 224 2.0× 32 833
Gerald E. Hancock United States 18 746 1.9× 546 2.0× 443 2.6× 257 1.8× 110 1.0× 30 1.4k
Maria Gabriella Donà Italy 20 667 1.7× 85 0.3× 87 0.5× 28 0.2× 188 1.7× 72 1.1k
Rossana Herrera United States 15 299 0.8× 196 0.7× 182 1.1× 20 0.1× 142 1.3× 23 768
Cyro Festa Neto Brazil 19 557 1.4× 162 0.6× 85 0.5× 165 1.2× 216 1.9× 88 1.2k
J Mĕstecký United States 12 96 0.2× 299 1.1× 62 0.4× 69 0.5× 127 1.1× 20 830
P Tabona United Kingdom 12 113 0.3× 612 2.3× 81 0.5× 57 0.4× 256 2.3× 14 887
Nigel J. Trendell‐Smith Hong Kong 15 171 0.4× 110 0.4× 185 1.1× 97 0.7× 37 0.3× 31 872
Kaori Uezu Japan 16 490 1.3× 784 2.9× 284 1.7× 57 0.4× 98 0.9× 20 1.2k
Jean Gupta United States 13 514 1.3× 772 2.9× 72 0.4× 27 0.2× 212 1.9× 14 1.4k

Countries citing papers authored by Bo Chi

Since Specialization
Citations

This map shows the geographic impact of Bo Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Chi more than expected).

Fields of papers citing papers by Bo Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Chi. The network helps show where Bo Chi may publish in the future.

Co-authorship network of co-authors of Bo Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Chi. A scholar is included among the top collaborators of Bo Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Chi. Bo Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Li, Jing, Gui‐Shan Tan, Ruihuan Liu, et al.. (2021). A novel Apigenin derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET. Biochemical Pharmacology. 190. 114620–114620. 12 indexed citations
2.
Blumenthal, Gideon M., Nancy S. Scher, Patricia Cortazar, et al.. (2013). First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer. Clinical Cancer Research. 19(18). 4911–4916. 89 indexed citations
3.
Cameron, Caroline E., et al.. (2008). Heterologous Expression of the Treponema pallidum Laminin-Binding Adhesin Tp0751 in the Culturable Spirochete Treponema phagedenis. Journal of Bacteriology. 190(7). 2565–2571. 22 indexed citations
4.
Kuramitsu, Howard K., Bo Chi, & Akihiko Ikegami. (2006). Genetic Manipulation of Treponema denticola. Current Protocols in Microbiology. 0(1). Unit 12B.2–Unit 12B.2. 14 indexed citations
5.
Chi, Bo, Harold Dickensheets, Kirsten Spann, et al.. (2006). Alpha and Lambda Interferon Together Mediate Suppression of CD4 T Cells Induced by Respiratory Syncytial Virus. Journal of Virology. 80(10). 5032–5040. 95 indexed citations
8.
Chi, Bo, Mingshan Qi, & Howard K. Kuramitsu. (2003). Role of dentilisin in Treponema denticola epithelial cell layer penetration. Research in Microbiology. 154(9). 637–643. 117 indexed citations
9.
Chi, Bo, Ronald J. Limberger, & Howard K. Kuramitsu. (2002). Complementation of a Treponema denticola flgE Mutant with a Novel Coumermycin A1-Resistant T. denticola Shuttle Vector System. Infection and Immunity. 70(4). 2233–2237. 23 indexed citations
10.
Chi, Bo, Sarita Chauhan, & Howard K. Kuramitsu. (1999). Development of a System for Expressing Heterologous Genes in the Oral SpirocheteTreponema denticolaand Its Use in Expression of theTreponema pallidum flaAGene. Infection and Immunity. 67(7). 3653–3656. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026